Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study

INTRODUCTION: Latanoprostene bunod (LBN) is a novel nitric oxide (NO)-donating prostaglandin F2α analog. We evaluated the long-term safety and intraocular pressure (IOP)-lowering efficacy of LBN ophthalmic solution 0.024% over 1 year in Japanese subjects with open-angle glaucoma (OAG) or ocular hype...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawase, Kazuhide, Vittitow, Jason L., Weinreb, Robert N., Araie, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020123/
https://www.ncbi.nlm.nih.gov/pubmed/27457469
http://dx.doi.org/10.1007/s12325-016-0385-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020123/
https://www.ncbi.nlm.nih.gov/pubmed/27457469
http://dx.doi.org/10.1007/s12325-016-0385-7

Ejemplares similares